News

Globant's AI Platform 2.3 Revolutionizes E-Commerce Transactions

Globant's AI Platform 2.3 Revolutionizes E-Commerce Transactions

Introducing Globant's AI Platform 2.3

Globant has unveiled its latest update to the Globant Enterprise AI (GEAI) platform, now at version 2.3. This innovative release has garnered significant attention from tech enthusiasts and businesses alike, offering advanced capabilities to transform the way enterprises operate. Notably, this rollout comes shortly after the announcement from OpenAI, signifying a timely response to the emerging demands in the tech space.

New Features of GEAI 2.3

One of the standout features of version 2.3 is the incorporation of the Agentic Commerce Protocol (ACP). This advancement allows businesses to optimize transactional processes using AI technology, enhancing customer interactions seamlessly. By allowing AI agents to facilitate purchases directly through conversational interfaces, organizations can now provide a more engaging and user-friendly experience.

Benefits of Agentic Commerce Protocol

The introduction of the ACP provides a robust framework for secure transactions, ensuring compatibility with existing payment systems while simplifying the buying process. Companies leveraging this technology can expect to see increased efficiency in their operations, ultimately enhancing their overall transaction capabilities.

Market Impact and Adaptation

Globant's AI platform has already exhibited profound effects across various sectors. Enterprises utilizing GEAI have reported substantial improvements, including an impressive 80% reduction in legacy system modernization times and a remarkable 50% decrease in software development costs. These metrics underline GEAI's commitment to driving innovation and adaptation within fast-paced environments.

Enhanced Interoperability

The latest update further boosts the platform's interoperability, enabling organizations to implement AI agents that can thrive across diverse environments. This effortless integration is essential for businesses looking to stay competitive and capitalize on AI advancements while managing their resources effectively.

Leadership Insights

Globant's leadership reflects a strong vision for the future of AI in enterprise settings. Martín Migoya, Co-founder and CEO, emphasized that the firm is focused on creating living ecosystems where AI plays a foundational role in business interactions. With the release of GEAI 2.3, the ability for AI Agents to conduct transactions marks a significant evolution in this vision.

Flexibility at Its Core

Gastón Milano, CTO of Globant Enterprise AI, elaborated on the platform's flexibility, which allows organizations to construct and adapt their agents quickly through an intuitive interface. The capability to securely execute transactions at scale not only strengthens business operations but also enhances the overall efficiency of various processes.

Looking Ahead with GEAI

The future looks promising for organizations invested in the capabilities of GEAI. As companies strive to adopt emerging technologies, the significant reductions in modernization time and costs provided by the platform position it as a vital resource for ongoing success. This innovative approach equips businesses with tools to meet evolving demands and drive transformative change.

Continuous Growth and Evolution

Underpinning this commitment to innovation, the platform’s evolution will be critical as it enables companies to navigate changing landscapes. Globant aims to stay at the forefront of AI development, pushing boundaries to create solutions that not only solve current challenges but anticipate future needs.

Frequently Asked Questions

What is Globant's Enterprise AI 2.3?

Globant's Enterprise AI 2.3 is an advanced platform incorporating the Agentic Commerce Protocol, designed to enhance business operations through AI-driven transactions.

How does the Agentic Commerce Protocol work?

The ACP facilitates direct transactions through conversational interfaces, allowing AI agents to handle purchases in a secure and efficient manner.

What benefits does GEAI provide to businesses?

Businesses utilizing GEAI have reported significant reductions in system modernization times and software development costs, thereby improving overall operational efficiency.

Who are the key figures at Globant?

Martín Migoya serves as the Co-founder and CEO, while Gastón Milano is the CTO of Globant Enterprise AI, both of whom emphasize AI's role in transforming business interactions.

How can companies adopt the new GEAI version?

The new version will be available by invitation and through a waitlist, allowing businesses to get involved with Globant's cutting-edge technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading